摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-[PdCl2(THT)2] | 14221-20-6

中文名称
——
中文别名
——
英文名称
trans-[PdCl2(THT)2]
英文别名
trans-bis(tetrahydrothiophene)Cl2palladium(II);trans-[PdCl2(tetrahydrothiophene)2];trans-[PdCl2(tetramethylene sulphide)2];dichloropalladium;thiolane
trans-[PdCl<sub>2</sub>(THT)2]化学式
CAS
14221-20-6
化学式
C8H16Cl2PdS2
mdl
——
分子量
353.673
InChiKey
LMVHHAITGFDSQJ-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    13.0
  • 可旋转键数:
    2.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0.0
  • 氢给体数:
    0.0
  • 氢受体数:
    0.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    trans-[PdCl2(THT)2]potassium cyanide 作用下, 以 二氯甲烷 为溶剂, 以95%的产率得到palladium(II) cyanide
    参考文献:
    名称:
    Uson, R.; Fornies, J.; Espinet, P., Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry, 1983, vol. 13, p. 513 - 526
    摘要:
    DOI:
  • 作为产物:
    描述:
    palladium dichloride 以 二氯甲烷 为溶剂, 以90%的产率得到trans-[PdCl2(THT)2]
    参考文献:
    名称:
    钯(II)和铂(II)的单核和双核阴离子五氟苯基配合物
    摘要:
    K 2 [MCl 4 ],[MCl 2(tht)2 ],MCl 2或[NBu 4 ] 2 [M 2(µ-Br)2 Br 4 ]的芳基化(M = Pd或Pt; tht =四氢噻吩)与LiR或MgBrR(R = C 6 F 5)结合生成通式[MR 3(tht)] –,[MR 4 ] 2–和[M 2(µ-Br)2 R 4 ] 2–,已分离为四烷基铵盐。[MR 3(tht)] -型化合物与中性配体的反应导致tht被L取代,[PdR 4 ] 2–的PdCl 2反应导致[Pd 2(µ-Cl )2 R 4 ] 2–,而[M 2(µ-X)2 R 4 ] 2–与Br –,I –或SCN –的碱金属盐反应给出(没有架桥系统的分裂)相应的复合物。已经分离和表征了这三种新型的二十种阴离子配合物。
    DOI:
    10.1039/dt9800000888
点击查看最新优质反应信息

文献信息

  • Effect of variation in ligand ring size upon the inversion barrier at sulphur in complexes of palladium(II) and platinum(II). A dynamic hydrogen-1 nuclear magnetic resonance study
    作者:Edward W. Abel、Martin Booth、Keith G. Orrell
    DOI:10.1039/dt9790001994
    日期:——
    the iodo-complexes. The pyramidal inversion energies are very dependent upon ligand ring size; those for five- and six-membered rings are comparable with complexes of linear sulphides, but the complexes of four-membered rings show a considerable heightening of the pyramidal sulphur inversion barrier. For the complexes of the three-membered ring sulphides no inversion was detectable up to the temperature
    该系列复合物的反式- [MX 2 [图形省略] R 2)Ñ } 2 ](M =II或Pt II ; X =,或I; R = H和/或Me; ñ = 2 –5)已合成,并且已通过带形拟合方法对它们的可变温度nmr光谱进行了精确分析,以确定在原子处发生字塔倒置的势垒。配合物中的势垒能比相应的化物高2–3 kJ mol –1,而化物则为4–5 kJ mol –1高于复合物。字塔形反转能量非常依赖于配体环的大小。五元环和六元环的那些与线性硫化物的配合物相当,但是四元环的配合物显示出字塔形转化阻挡层的显着提高。对于三元环硫化物的络合物,直到分解开始的温度都没有检测到反转,这是在二烷基硫化物属络合物中这种刚性的第一个报道实例。
  • [(Piperidinomethyl)silylmethyl] Cyclopalladated Complexes:  Their Synthesis, Reactivity, and Solid State Structures<sup>⊥</sup>
    作者:Daniel Schildbach、Marta Arroyo、Klaus Lehmen、Susana Martín-Barrios、Luisa Sierra、Fernando Villafañe、Carsten Strohmann
    DOI:10.1021/om040028+
    日期:2004.6.1
    obtained from the latter compound upon treatment with TlBF4. The chelate complexes [PdCH2SiPh2(CH2NC5H10)-κ2C,N}(acac)] (16) (acac = acetylacetonate) and [PdCH2SiPh2(CH2NC5H10)-κ2C,N}(S2CNEt2)] (15) are obtained by reaction of the starting chloro-bridged dimer 3 with Tl(acac) and NaS2CNEt2, respectively. The solid state structures of palladacycles 3, 4, 8, 9, 10, and 15 were determined by X-ray diffraction
    Ph 2 Si(CH 2 Li)(CH 2 NC 5 H 10)(2)(CH 2 NC 5 H 10 =哌啶子基甲基)与反式-[PdCl 2(SMe 2)2 ]的反应生成二聚体[Pd c ^ H ^ 2 SIPH 2(CH 2 ñ ç 5 ħ 10)-κ 2 C,N }(μ-Cl)的] 2(3),其中[ C ^ H ^ 2 SIPH 2(CH 2 Ñ Ç 5 ħ 10)-κ 2 C,N ]配体形成的环,如发现通过的晶体结构transoid异构体。在溶液中,该桥二聚体以顺式和反式异构体的混合物形式存在。单齿配体切割的二聚体桥3以得到型化合物[ c ^ H ^ 2 SIPH 2(CH 2 Ñ Ç 5 ħ 10)-κ 2 C,N } CLL] [L = PPH 3(4),聚甲基丙烯酸甲酯3(5),CN tBu(6),4-甲基吡啶(4-MePy)(7),四氢噻吩(tht)(8),SMe
  • Functional isocyanide metal complexes as building blocks for supramolecular materials: hydrogen-bonded liquid crystals
    作者:Silverio Coco、Elisa Espinet、Pablo Espinet、Inés Palape
    DOI:10.1039/b705478e
    日期:——
    Gold, palladium and platinum complexes with an unusual isocyanide ligand containing a carboxylic acid function, [AuCl(CNC6H4COOH)], cis-[MI2(CNC6H4COOH)2] and trans-[MI2(CNC6H4COOH)2] (M = Pd, Pt) have been isolated. The carboxylic acid group of the coordinated isocyanide acts as a hydrogen donor for hydrogen-bonding and three series of stable hydrogen-bonded liquid crystalline metal complexes have been prepared with decyloxystilbazole. Although all the metal acid derivatives used are not mesomorphic, and decyloxystilbazole only shows an ordered Smectic E phase, four out of the five hydrogen-bonded decyloxystilbazole complexes studied display enantiotropic smectic A or nematic mesophases. The single crystal X-ray diffraction structure of trans-[PdI2(CNC6H4COOH)2]·C4H8O2 has been determined and confirms the formation of a supramolecular array in the solid state supported by hydrogen-bonding.
    的配合物与一种含有羧酸功能的非典型异配体[AuCl(CNC6H4COOH)]、顺式-[MI2(CNC6H4COOH)2]和反式-[MI2(CNC6H4COOH)2](M = Pd,Pt)已被分离。配位异基的羧酸基团作为氢供体参与氢键的形成,并且已与十氮烯基苯甲醚制备出三系列稳定的氢键液晶属配合物。尽管所用的所有属酸衍生物均不具备液晶性,并且十氮烯基苯甲醚仅显示有序的层状E相,所研究的五个氢键十氮烯基苯甲醚配合物中有四个显示出对称行为的层状A相或内相。反式-[PdI2(CNC6H4COOH)2]·C4H8O2的单晶X射线衍射结构已被确定,确认在固态中通过氢键形成了超分子阵列。
  • <i>o</i>- and <i>m</i>-(Bromotetrafluorophenyl)palladium(II) Complexes:  Atropisomerism Studies by <sup>19</sup>F NMR and Measurement of Through-Space F−F Coupling Constants
    作者:Ana C. Albéniz、Arturo L. Casado、Pablo Espinet
    DOI:10.1021/om970529d
    日期:1997.12.1
    anti atropisomer is preferred in the cis-o-C6BrF4 derivatives, particularly if the ancillary ligands extend out of the coordination plane. Strong through-space coupling between syn Fortho atoms of mutually cis R groups is observed in the 19F NMR spectra for cis-[Pd(C6BrF4)2L2] complexes. J-values were determined which prove useful to unequivocally identify the atropisomers formed and to detect distortions
    合成了具有不对称芳基o -C 6 BrF 4和m -C 6 BrF 4的(II)配合物,即[Pd 2(C 6 BrF 4)2(μ-Cl)2(THT)2 ],反式- [(C 6 BRF 4)THT)2 ](THT =四氢噻吩),反式- [(C 6 BRF 4)2大号2 ],和顺- [(C 6 BRF 4)2大号2 ](L 2 = 2THT,COD中,Me 2联吡啶4,4'-二甲基-2,2'-联吡啶),OPPy 2 Ph(上PY = 2-吡啶基),2PMe 3,2CNMe)。阻转异构体的混合物(顺式-和抗-)被发现,对于大多数二(芳基)络合物,和的比顺式:反阻转异构体,取决于R基团时,顺式或反式的复合物的几何形状,和辅助配体:一个比接近1:1,观察到的顺式-和反式-米-C6个BRF 4衍生物和用于反式- ø -C 6 BRF 4种配合物,但是抗阻转异构体是优选的,所述顺式-
  • 3,5-dichlorotrifluorophenyl complexes, aryl derivatives with simple 19F NMR structural probes. The synthesis of general precursors for Pd- and Pt complexes
    作者:Pablo Espinet、Jesús M. Martı́nez-Ilarduya、Celeste Pérez-Briso、Arturo L. Casado、M.Aránzazu Alonso
    DOI:10.1016/s0022-328x(97)00424-5
    日期:1998.1
    High yield methods for the synthesis of cis-[MR2(COD)] (M=Pd, Pt; R=3,5-C6Cl2F3), cis-[MR2(THF)2] (M=Pd; Pt), trans-[PdR2L2] (L=tht; SMe2), trans-[PtR2(SMe2)2], and [M2(μ-Cl)2R2L2] (M=Pd, L=NCPh, tht, SMe2; M=Pt, L=tht) are reported. These complexes are general precursors for the preparation of other complexes containing cis-MR2, trans-MR2 and MClR moieties in almost quantitative yields. Thus, by displacement
    高产率合成顺式-[MR 2(COD)](M = Pd,Pt; R = 3,5-C 6 Cl 2 F 3),顺式-[MR 2(THF)2 ](M = Pd; Pt),反式-[PdR 2 L 2 ](L = tht; SMe 2),反式-[PtR 2(SMe 2)2 ]和[M 2(μ- Cl)2 R 2 L 2 ]( M = Pd,L = NCPh,tht,SMe 2; 报告M = Pt,L = tht)。这些络合物是用于制备几乎以定量产率包含顺式-MR 2,反式-MR 2和MC1R部分的其他络合物的一般前体。因此,通过用其他配体置换COD,THF,tht或SMe 2,可以制备具有一个或两个芳基环的任何配合物的几乎任何异构体。与其他多氟苯基相比,这些配合物的19 F NMR光谱简单,并给出了这种部分化的配体的光谱优势的一些实例。
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)